Stock Market 22 May 2026 - 23 May 2026

Quantum-Si Stock Jumps as Traders Bet on Proteus Launch — Here’s What Could Move QSI Next
····

Quantum-Si Stock Jumps as Traders Bet on Proteus Launch — Here’s What Could Move QSI Next

Quantum-Si shares jumped 5.5% to $1.245 Tuesday, with no new company news, as traders focused on the Proteus platform launch expected later this year. Volume reached 3.1 million shares, market value near $270 million. First-quarter revenue fell 69% to $258,000, net loss widened to $21.7 million. The company reported $190.4 million in cash at March 31, enough to fund operations into Q2 2028.
June 2, 2026
Microvast Shares Edge Higher as Investors Weigh Filing Uncertainty
····

Microvast Shares Edge Higher as Investors Weigh Filing Uncertainty

Microvast Holdings shares rose 5.43% to $1.4550 on Friday, outpacing major indexes despite no new company news ahead of the Memorial Day market closure. The latest SEC filing showed CTO Wenjuan Mattis sold 48,346 shares for tax withholding. Microvast reported a 48% revenue drop and a $5.5 million adjusted EBITDA loss in Q1. Its 10-Q warned existing cash may not cover 12 months of operations.
May 23, 2026
Magyar Bancorp Stock Edges Down After Dividend Day, Tiny Volume in Focus
····

Magyar Bancorp Stock Edges Down After Dividend Day, Tiny Volume in Focus

Magyar Bancorp shares fell 0.85% to $17.45 on Nasdaq Friday, with volume at 3,850 shares, about double the average. The drop followed the company’s quarterly dividend payment date. Net income for the March quarter rose 13% to $3 million, but the provision for credit losses increased to $256,000 from a $30,000 recovery a year earlier. The broader market ended higher, with the Russell 2000 up 0.9%.
May 23, 2026
Kodiak Sciences Falls Before Holiday Pause With Eyes on Drug Update
····

Kodiak Sciences Falls Before Holiday Pause With Eyes on Drug Update

Kodiak Sciences shares fell 3.2% to $36.23 Friday, ending a volatile week ahead of a three-day U.S. market closure. No new company updates were posted; investors await late-stage trial results for Zenkuda, Kodiak’s experimental retina drug. The stock remains above pre-March levels, after Zenkuda met a key Phase 3 goal for diabetic retinopathy. One-year data from a wet AMD trial is expected in September.
May 22, 2026
BioAge Stock Dropped Before June Investor Call on Key Drug
····

BioAge Stock Dropped Before June Investor Call on Key Drug

BioAge Labs shares fell 0.8% to $16.61 Friday, trailing a stronger Nasdaq. The company set June 4 investor meetings but released no new clinical data. Investors are watching for two mid-2026 proof-of-concept trials of BGE-102, its oral NLRP3 inhibitor for cardiovascular and retinal diseases. April Phase 1 data showed at least 85% median reductions in hsCRP, with no serious adverse events.
May 22, 2026
Enterprise Financial stock adds to gains before holiday weekend
····

Enterprise Financial stock adds to gains before holiday weekend

Enterprise Financial Services shares closed up 0.2% at $60.82 on Friday, capping a roughly 4% gain for the week as regional bank stocks edged higher ahead of the Memorial Day break. Trading volume followed sector trends rather than new company news, with investors still reacting to April’s first-quarter results showing net income of $49.4 million and a slight rise in net interest margin to 4.28%.
May 22, 2026
ABTS Stock Still Trading Under $1, But Traders Are Watching This Small Bitcoin Miner
····

ABTS Stock Still Trading Under $1, But Traders Are Watching This Small Bitcoin Miner

Abits Group Inc. shares traded at $0.8602, up 0.93% Friday, but stayed near a 52-week low as light volume preceded the Memorial Day weekend. The bitcoin miner reported 2025 revenue of $9.13 million and a $2.87 million after-tax loss. Year-end cash fell to $83,837, while digital assets rose to $1.48 million. The stock remains below $1, raising continued Nasdaq listing concerns.
May 22, 2026
LOKV Holds at $10.53 as Teamshares Deal Deadline Nears
····

LOKV Holds at $10.53 as Teamshares Deal Deadline Nears

Live Oak Acquisition Corp. V shares hovered near $10.53 Friday with light trading, as investors awaited progress on its merger with Teamshares. The companies extended their merger deadline to July 15 and filed an amended Form S-4/A with the SEC on May 19. Live Oak’s trust account backs 23 million shares at $10.48 each, keeping the stock close to redemption value. The deal values the combined company at $746 million.
May 22, 2026
X-Energy Shares Hit Wall Street After IPO With Focus On Nuclear Potential
····

X-Energy Shares Hit Wall Street After IPO With Focus On Nuclear Potential

X-Energy shares held near $29 on Friday, about a month after its $23 Nasdaq IPO that raised $1.02 billion. The company will report first-quarter results June 4, its first as a public firm. Analysts have turned mostly positive, with price targets ranging from $28 to $57. The U.S. Nuclear Regulatory Commission cleared an environmental review for X-Energy’s Long Mott project in Texas this week.
May 22, 2026
Why Versus Systems Stock Is Hovering Near $1 Before a Nasdaq Deadline
····

Why Versus Systems Stock Is Hovering Near $1 Before a Nasdaq Deadline

Versus Systems Inc. traded near $1 Friday with only 6,560 shares changing hands, far below its average volume, as the company faces a Nasdaq compliance deadline. Versus reported $1.2 million in stockholders’ equity at March 31, below the $2.5 million minimum, and is awaiting proceeds from a $1.7 million stock sale to ASPIS Cyber Technologies. First-quarter revenue fell 91% to $17,300.
May 22, 2026
GTEC Trades Higher Even as $1 Rule Stays in Focus
····

GTEC Trades Higher Even as $1 Rule Stays in Focus

Greenland Technologies shares rose 2.5% to $0.58 Friday, still well below Nasdaq’s $1 minimum bid requirement. The company has until Sept. 8 to regain compliance or risk delisting. Q1 revenue climbed to $25.54 million and net income to $5.75 million, but EPS fell as share count increased. Most sales come from transmission products for Chinese forklift makers; its U.S. electric vehicle unit remains mostly suspended.
May 22, 2026
Caribou Biosciences Holds Near $2 With June Cancer Drug Updates Ahead
····

Caribou Biosciences Holds Near $2 With June Cancer Drug Updates Ahead

Caribou Biosciences shares rose about 1% to $2.01 on Friday ahead of cancer drug data updates expected in June. The company plans to present new results on vispa-cel and CB-011 at the European Hematology Association meeting. Caribou had $118.6 million in cash at March 31 and raised $2.3 million by selling 1.08 million shares in the first quarter. The stock traded before a three-day U.S. market holiday.
May 22, 2026
KNDI Shares Stay Below $1 as Nasdaq Deadline Looms
····

KNDI Shares Stay Below $1 as Nasdaq Deadline Looms

Kandi Technologies shares traded at 72 cents Friday morning in New York, remaining below Nasdaq’s $1 minimum bid requirement. The company has until Nov. 2 to regain compliance or risk delisting. Kandi reported 2025 net revenue of $87.4 million, down sharply from 2024, with most sales from off-road vehicles. Broader U.S. markets rose ahead of Memorial Day, but Kandi’s stock lagged.
May 22, 2026
1 … 13 14 15 16 17 … 127

Stock Market Today

  • FTSE 100 Stocks Glencore and Fresnillo: Are They Still Top Buys After 100%+ Gains?
    June 2, 2026, 11:50 AM EDT. Shares of Glencore and Fresnillo, both FTSE 100 miners, have soared over 100% amid rising demand for copper and silver. Glencore focuses on copper, a key metal for electrification and AI-driven tech, expecting a structural shortfall that supports output growth to 1.6m tonnes by 2035. Fresnillo's silver has been volatile but benefits from sustained central bank buying and industrial demand in energy transition tech. Despite price swings, strong fundamentals and margin leverage remain. Commodity price volatility and energy cost risks pose challenges. Investors should weigh if future earnings are adequately priced, as both stocks retain potential driven by long-term supply-demand imbalances and industrial uses.